Chemotherapy for Endometrial Cancer — When It Is Actually Used

For most women, no. Chemotherapy is not part of routine treatment for early-stage, low-grade endometrioid endometrial cancer, where surgery — sometimes followed by vaginal vault brachytherapy — is standard and frequently sufficient. This surprises many women, particularly those who know someone treated for breast or ovarian cancer where chemotherapy is far more routine. It is recommended for specific situations: advanced or metastatic disease, recurrent disease, aggressive histological types such as serous or clear cell carcinoma even at early stage, lymph node involvement, or high-risk disease where it is combined with radiation. If it has been proposed for early low-grade disease, ask what specifically justifies it.

They solve different problems and are frequently used together rather than as alternatives. Radiation treats a defined area — the vaginal vault, or the pelvis — very thoroughly, and does nothing outside that area. Chemotherapy circulates through the body, so it reaches cells that may have travelled anywhere, but treats no single area as intensively. In higher-risk endometrial cancer both risks exist: the cancer may return where it was, and cells may already have travelled elsewhere. That is why combined chemoradiotherapy is used in high-risk disease. Understanding this makes a combined plan look less like being given everything available and more like addressing two distinct risks.

A repeating pattern, usually every three weeks. Before each cycle, blood tests confirm your bone marrow has recovered and a review appointment adjusts doses based on how the previous cycle went. Treatment itself is given through a drip in a day unit over several hours, including pre-medications, and you go home the same day. Days two to seven are typically the hardest, with fatigue and any nausea. Days seven to fourteen are when white cell counts are lowest and infection risk is highest, though you will feel no different. Days fourteen to twenty-one are recovery, and many women feel close to normal by the end.

That a fever after chemotherapy is a medical emergency requiring immediate action, not something to sleep on. Chemotherapy lowers the white blood cells that fight infection, and an infection occurring while those counts are low can become dangerous within hours. You will be given a twenty-four hour contact number: call it immediately for a temperature, shivering or rigors, or simply feeling suddenly and unaccountably unwell — at any hour, on any day, and even if you feel you are making a fuss. Do not take paracetamol first, because it masks the fever. Treatment is prompt antibiotics, and promptness is what makes the difference.

Possibly, and it is worth asking specifically. Two questions open that door. First, has your tumour been tested for mismatch repair status — a deficient result may make checkpoint immunotherapy an option, which is a different and often better-tolerated treatment. Second, is your tumour hormone-receptor positive and low grade — because progestin hormone therapy can control that kind of advanced or recurrent disease for a considerable period at far lower toxicity than chemotherapy, and is a legitimate first-line choice in the right woman rather than a fallback. Both results come from tissue already removed and require no new procedure.